Pharma giant partners with Durham firm to target sickle cell disease
IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...
Faces to Watch in 2025: He leads drugmaker's multibillion-dollar expansion in NC
A longtime veteran of the pharma industry is leading a $4 billion expansion in Johnston County. In a year full of big ...
PipelineReview.com4h
Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
DURHAM, NC, USA I2, 2025 I IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human ...
ncbiotech.org1d
IMMvention Therapeutix to collaborate with Novo Nordisk on oral therapies for sickle cell, other chronic diseases
IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...
The Herald-Sun27d
The 5 biggest NC job announcements of 2024: A different kind of battery maker tops the list
Excavators at the future Novo Nordisk expansion site in Clayton, NC hoist up U.S., Denmark, and North Carolina flags on June 24, 2024. Brian Gordon bgordon@newsobserver Boviet Solar, 908 jobs ...
IMMvention Therapeutix Enters Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...